IBDoc® Calprotectin Home Testing
Alpha Laboratories has expanded its offering of BÜHLMANN Calprotectin tests with the launch of IBDoc®, the first CE marked Calprotectin home test.
The supplier does not provide quotations for this product through SelectScience. You can search for similar products in our Product Directory.
Great results & User friendly App with Phone calibration
Excellent correlation with laboratory based tests, User friendly App with Phone calibration.
Excellent correlation with laboratory based tests. Quantitative rapid test with measurement of calprotectin in the range 30 – 1000µg/g Simple sample preparation devices minimises pre-analytical errors, User friendly App with Phone calibration.
Review Date: 26 Jul 2022 | Alpha Laboratories Ltd
Under the guidance of clinicians, regular monitoring is now possible for IBD patients in the comfort of their own home.
This allows for a customised, patient centric approach for therapy and disease management helping to predict possible relapse and assisting with therapy optimisation.
Method:
Process the sample with the CALEX®
Apply the extracted sample to the calprotectin cassette
Use the smartphone CalApp® to read and calculate the result and send it to the gastroenterologist via the secure IBDoc® Portal
Brochures
IBDoc® Calprotectin Home Test: A Step Forward towards Patient Empowerment
This product brochure presents BUHLMANN’s IBDoc® Calprotectin Home Test. Calprotectin is the most useful biomarker for assessing healing as well as predicting the disease course and risk for relapse for inflammatory bowel disease. IBDoc® Calprotectin Home Test empowers the patient to actively participate in their disease management. With this home test and the supporting Smartphone App, calprotectin test results can be sent remotely to physicians giving a flexible option for disease monitoring and improving the quality of care the patient receives.
IBD Management - Power to the Patient
This scientific poster presents BUHLMANN’s IBDoc® home testing system. Managing chronic conditions such as diabetes and hypertension through patient self-testing has become common place. It is now possible for sufferers of inflammatory bowel disease (IBD) to manage their condition at home. This self-testing approach will enable increased frequency of monitoring. This will help identify patients likely to relapse, so that their treatment can be adapted early, to ease, or even prevent, possible deterioration.
Using the IBDoc® Calprotectin Home Test
This video demonstrates how to use the IBDoc® Calprotectin Home Test and the smartphone CalApp® in three easy steps.
